TSTickerStarGet alerts

Xanadu Q3 2026 Loss Widens to $32.2M; Revenue Rises 32% YoY to $1.3M

Xanadu reported Q3 2026 revenue of $1.3 million, a 32% year-over-year increase driven by DARPA QBI revenue and partnership engagements, partially offset by completion of prior-year contracts. The company reported a net loss of $32.2 million compared to a loss of $20.3 million in Q3 2025, while Adjusted EBITDA loss widened to $26.3 million from $15.4 million. R&D expense increased 67% year-over-year to $25.6 million due to higher engineering headcount and material costs, and G&A expense rose 129% to $9.2 million...

Share this story

Key takeaways

  • Revenue: $1.3 million in Q3 2026, up 32% YoY from $987 thousand in Q3 2025.

  • Net loss: $32.2 million in Q3 2026 versus $20.3 million loss in Q3 2025.

  • Adjusted EBITDA loss: $26.3 million in Q3 2026 compared to $15.4 million loss in Q3 2025.

  • R&D expense: $25.6 million, up 67% YoY due to increased engineering headcount and material consumption costs.

  • Cash position: $286.5 million as of September 30, 2026, up from $16.2 million at December 31, 2025.

  • Government funding: Definitive agreement for approximately $140 million in federal funding through Canada's Strategic Response Fund for the Inception facility.

  • Conference call scheduled for November 11, 2026 at 5:30 PM EST.

Key metrics

Total RevenueQ3 2026 (three months ended September 30, 2026)
$1.305 million32% increase
Total Revenue (Nine Months)Nine months ended September 30, 2026
$5.648 million106% increase
Net LossQ3 2026
$32.196 millionLoss widened from $20.298 million
Net Loss (Nine Months)Nine months ended September 30, 2026
$94.851 millionLoss widened from $47.643 million
Adjusted EBITDA LossQ3 2026
$26.270 millionLoss widened from $15.446 million
Adjusted EBITDA Loss (Nine Months)Nine months ended September 30, 2026
$61.485 millionLoss widened from $39.495 million
Net Loss Per Share (Basic and Diluted)Q3 2026
$(0.11)Improved from $(0.36) in Q3 2025 (per share data retroactively recast for reverse recapitalization)
Research and Development ExpenseQ3 2026
$25.560 million67% increase

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow XNDU in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert